Benzinga's Top Upgrades, Downgrades For September 18, 2020

Upgrades

  • For Fox Factory Holding Corp FOXF, Stifel upgraded the previous rating of Hold to the current rating Buy. Fox Factory Hldg earned $0.50 in the second quarter, compared to $0.68 in the year-ago quarter. The current stock performance of Fox Factory Hldg shows a 52-week-high of $113.41 and a 52-week-low of $34.58. Moreover, at the end of the last trading period, the closing price was at $75.59.
  • Morgan Stanley upgraded the previous rating for II-VI Inc IIVI from Equal-Weight to Overweight. For the fourth quarter, II-VI had an EPS of $1.18, compared to year-ago quarter EPS of $0.67. The stock has a 52-week-high of $52.97 and a 52-week-low of $19.00. At the end of the last trading period, II-VI closed at $37.89.
  • For Kinross Gold Corp KGC, BMO Capital upgraded the previous rating of Market Perform to the current rating Outperform. In the second quarter, Kinross Gold showed an EPS of $0.15, compared to $0.06 from the year-ago quarter. The current stock performance of Kinross Gold shows a 52-week-high of $10.21 and a 52-week-low of $2.72. Moreover, at the end of the last trading period, the closing price was at $9.37.
  • Stifel upgraded the previous rating for Dave & Buster's Entertainment Inc PLAY from Hold to Buy. For the second quarter, Dave & Buster's Enter had an EPS of $1.24, compared to year-ago quarter EPS of $0.90. At the moment, the stock has a 52-week-high of $48.80 and a 52-week-low of $4.61. Dave & Buster's Enter closed at $14.12 at the end of the last trading period.
  • Morgan Stanley upgraded the previous rating for SunPower Corp SPWR from Underweight to Equal-Weight. In the second quarter, SunPower showed an EPS of $0.22, compared to $0.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.57 and a 52-week-low of $4.03. SunPower closed at $9.89 at the end of the last trading period.

 

Downgrades

  • For Apartment Investment & Management Co AIV, Citigroup downgraded the previous rating of Neutral to the current rating Sell. For the second quarter, Apartment Inv & Mgmt had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. The current stock performance of Apartment Inv & Mgmt shows a 52-week-high of $55.68 and a 52-week-low of $24.53. Moreover, at the end of the last trading period, the closing price was at $36.38.
  • According to Citigroup, the prior rating for Mirati Therapeutics Inc MRTX was changed from Buy to Neutral. Mirati Therapeutics earned $1.89 in the second quarter, compared to $1.26 in the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $171.48 and a 52-week-low of $66.01. Moreover, at the end of the last trading period, the closing price was at $161.97.
  • Wells Fargo downgraded the previous rating for NovoCure Ltd NVCR from Overweight to Equal-Weight. NovoCure earned $0.02 in the second quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $110.87 and a 52-week-low of $53.40. NovoCure closed at $108.98 at the end of the last trading period.
  • According to Chardan Capital, the prior rating for Seres Therapeutics Inc MCRB was changed from Buy to Neutral. Seres Therapeutics earned $0.28 in the second quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $33.00 and a 52-week-low of $2.52. Seres Therapeutics closed at $26.86 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Beyond Meat Inc BYND was changed from Neutral to Underweight. Beyond Meat earned $0.02 in the second quarter, compared to $0.06 in the year-ago quarter. The current stock performance of Beyond Meat shows a 52-week-high of $167.16 and a 52-week-low of $48.18. Moreover, at the end of the last trading period, the closing price was at $157.22.
  •  

Initiations

  • B. Riley FBR initiated coverage on Abeona Therapeutics Inc ABEO with a Buy rating. The price target for Abeona Therapeutics is set to $5.00. Abeona Therapeutics earned $0.14 in the second quarter, compared to $0.49 in the year-ago quarter. The current stock performance of Abeona Therapeutics shows a 52-week-high of $5.19 and a 52-week-low of $1.35. Moreover, at the end of the last trading period, the closing price was at $1.96.
  • With a current rating of Buy, Berenberg initiated coverage on Ambarella Inc AMBA. The price target seems to have been set at $67.00 for Ambarella. In the second quarter, Ambarella showed an EPS of $0.06, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $73.59 and a 52-week-low of $36.02. At the end of the last trading period, Ambarella closed at $52.19.
  • Compass Point initiated coverage on Argo Group International Holdings Ltd ARGO with a Buy rating. The price target for Argo Gr Intl Hldgs is set to $41.00. For the second quarter, Argo Gr Intl Hldgs had an EPS of $0.14, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $70.89 and a 52-week-low of $25.00. At the end of the last trading period, Argo Gr Intl Hldgs closed at $35.59.
  • With a current rating of Outperform, Cowen & Co. initiated coverage on BioLife Solutions Inc BLFS. The price target seems to have been set at $33.00 for BioLife Solutions. In the second quarter, BioLife Solutions showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. The stock has a 52-week-high of $28.28 and a 52-week-low of $7.37. At the end of the last trading period, BioLife Solutions closed at $25.43.
  • Goldman Sachs initiated coverage on Intellia Therapeutics Inc NTLA with a Buy rating. The price target for Intellia Therapeutics is set to $33.00. For the second quarter, Intellia Therapeutics had an EPS of $0.61, compared to year-ago quarter EPS of $0.56. The stock has a 52-week-high of $25.56 and a 52-week-low of $9.18. At the end of the last trading period, Intellia Therapeutics closed at $22.45.
  • With a current rating of Buy, Benchmark initiated coverage on MACOM Technology Solutions Holdings Inc MTSI. The price target seems to have been set at $47.00 for MACOM Technology. For the third quarter, MACOM Technology had an EPS of $0.33, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $44.69 and a 52-week-low of $15.03. At the end of the last trading period, MACOM Technology closed at $32.79.
  • With a current rating of Hold, Truist Securities initiated coverage on Strategic Education Inc STRA. The price target seems to have been set at $105.00 for Strategic Education. In the second quarter, Strategic Education showed an EPS of $2.06, compared to $1.59 from the year-ago quarter. The current stock performance of Strategic Education shows a 52-week-high of $187.97 and a 52-week-low of $87.80. Moreover, at the end of the last trading period, the closing price was at $93.80.
  • With a current rating of Buy, Citigroup initiated coverage on Utz Brands Inc UTZ. The price target seems to have been set at $21.00 for Utz Brands. At the moment, the stock has a 52-week-high of $19.16 and a 52-week-low of $15.98. Utz Brands closed at $17.91 at the end of the last trading period.
  • With a current rating of Buy, Stifel initiated coverage on Construction Partners Inc ROAD. The price target seems to have been set at $21.00 for Construction Partners. For the third quarter, Construction Partners had an EPS of $0.30, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $22.15 and a 52-week-low of $11.96. Construction Partners closed at $17.89 at the end of the last trading period.
  • With a current rating of Outperform, Wedbush initiated coverage on Retrophin Inc RTRX. The price target seems to have been set at $33.00 for Retrophin. For the second quarter, Retrophin had an EPS of $0.22, compared to year-ago quarter EPS of $0.58. The current stock performance of Retrophin shows a 52-week-high of $21.92 and a 52-week-low of $8.98. Moreover, at the end of the last trading period, the closing price was at $19.67.
  • Piper Sandler initiated coverage on Intuit Inc INTU with an Overweight rating. The price target for Intuit is set to $351.00. Intuit earned $1.81 in the fourth quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $360.00 and a 52-week-low of $187.68. At the end of the last trading period, Intuit closed at $307.23.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Penny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsHealth CareHealth Care EquipmentInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!